Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Parkinson's disease
Biotech
Angelini pens $360M biobucks pact for ph. 1 brain disorder drug
Italy’s Angelini Pharma has signed a $360 million biobucks pact centered on a phase 1-stage brain health drug from South Korea’s Cureverse.
James Waldron
Oct 21, 2024 10:04am
MeiraGTx Parkinson's gene therapy boosts motor function in ph. 2
Oct 15, 2024 7:00am
AbbVie Parkinson's drug from $8.7B Cerevel buyout scores
Sep 26, 2024 10:45am
NIH leader's research misconduct calls drugs into question
Sep 26, 2024 9:12am
Sanofi makes $27M equity investment in Ventyx
Sep 23, 2024 11:24am
Medtronic details study of adaptive neurostim in Parkinson’s
Sep 18, 2024 12:15pm
